Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

9 treatments under study, led by Followup

Related Conditions

Often studied with 10 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 37/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

1Total
Phase 2 (1)

Trial Status

Completed2

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 2 completed trials

Clinical Trials (2)

Showing 2 of 2 trials
NCT05130073Completed

4-Point Therapy Response Score With PET/CT for Anal Squamous Cell Cancer

NCT03690921Phase 2Completed

Linear Energy Transfer (LET)-Optimized Intensity Modulated Proton Therapy (IMPT) as a Component of Definitive Chemoradiation for Newly Diagnosed Squamous Cell Carcinoma of the Anal Canal: a Feasibility Trial

Showing all 2 trials

Research Network

Common Treatments

  • Followup1
  • Computed Tomography1
  • Linear Energy Transferoptimized Intensity Modulated Proton Therapy1
  • Fluorouracil1
  • Electronic Health Record Review1

Active Sponsors

  • M.D. Anderson Cancer Center2
  • National Cancer Institute (NCI)2

Top Investigators

Related Conditions

  • Stage Iiic Anal Cancer Ajcc V82
  • Stage Iii Anal Cancer Ajcc V82
  • Stage Iia Anal Cancer Ajcc V82
  • Stage Iib Anal Cancer Ajcc V82
  • Stage Ii Anal Cancer Ajcc V82

Activity Timeline